CLINICAL_TRIALS
trial_result
· 2023-12-08
Clinical Trial Update: Control-IQ Observational (CLIO) Post-Approval Study
Summary
Post-approval observational study CLIO completed; results posted in 2023, evaluating Control-IQ in Type 1 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tandem Diabetes Care, Inc. | Conditions: Diabetes Mellitus, Type 1 | Status: COMPLETED | Results posted: 2023-12-08